𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Implications of increased bone density in osteoarthritis

✍ Scribed by Dr. David Hamerman; E. Richard Stanley

Publisher
American Society for Bone and Mineral Research
Year
2009
Tongue
English
Weight
413 KB
Volume
11
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bone density and local growth factors in
Bone density and local growth factors in generalized osteoarthritis
✍ Dequeker, Jan; Mokassa, Luc; Aerssens, Jeroen; Boonen, Steven πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 330 KB

Osteoarthritis is usually considered to be a primary disorder of chondrocyte function with secondary changes in bones. However, a defect in the subchondral bone resulting in loss of its shock absorbing capacity could transfer the stress of loading directly to the articular cartilage with secondary c

Association of radiographically evident
Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age. The rotterdam study
✍ Huibert Burger; Paulus L. A. van Daele; Else Odding; Hans A. Valkenburg; Albert πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 528 KB

To investigate the relationship of osteoarthritis (OA) to bone mineral density (BMD) and rate of bone loss. Methods. The study group consisted of 2,745 persons (1,624 women) from the general elderly population. Disability was assessed by the Health Assessment Questionnaire. Femoral neck BMD was mea

Two doses of sclerostin antibody in cyno
Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
✍ Michael S Ominsky; Fay Vlasseros; Jacquelin Jolette; Susan Y Smith; Brian Stouch πŸ“‚ Article πŸ“… 2010 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 691 KB

## Abstract The development of bone‐rebuilding anabolic agents for treating bone‐related conditions has been a long‐standing goal. Genetic studies in humans and mice have shown that the secreted protein sclerostin is a key negative regulator of bone formation. More recently, administration of scler